The Mice Model Market size was valued at USD 1.60 Billion in 2024 and the total Mice Model revenue is expected to grow at a CAGR of 6.8% from 2025 to 2032, reaching nearly USD 2.71 Billion.Global Mice Model Market Overview:
This growth is fuelled by several factors. Advancements in creating new and improved mice models are making them more relevant for research. The rise of personalized medicine is increasing the demand for these models to test the effectiveness of treatments tailored to individual patients. The increasing pipelines of pharmaceutical and biopharmaceutical companies necessitate more preclinical testing, further driving the mice model market. The market also faces challenges. Ethical concerns surrounding animal testing and regulations aimed at ensuring the ethical use of animals hinder growth. Additionally, the development of alternative testing methods potentially replace the need for mice models in some instances. Despite these challenges, the mice model market is expected to maintain its upward trajectory due to the ongoing need for reliable preclinical testing in various research fields.To know about the Research Methodology:-Request Free Sample Report Advancements in gene editing techniques The emergence of CRISPR gene editing is a game-changer for the mice model market. Earlier, generating mice with specific diseases or mutations was a laborious and error-prone process. This limited the accuracy and reliability of preclinical testing, a critical bottleneck in drug discovery. However, CRISPR offers a much faster, more targeted, and cost-effective approach to manipulating the mouse genome. This translates to mice models that more faithfully mimic human diseases. For instance, scientists now introduce disease-causing mutations with pinpoint accuracy, creating highly relevant models for studying disease progression and potential treatments. The impact goes beyond just mimicking diseases. CRISPR allows for the development of humanized mice by incorporating specific human genes or tissues. This significantly narrows the gap between preclinical testing in mice and human trials, accelerating the entire drug development process. The ease and precision of CRISPR editing streamline the creation of sophisticated and human-relevant mice models. This translates to faster and more reliable preclinical testing, ultimately fuelling the growth of the mice model market. This trend to continue, with increasing demand for these improved models driving Mice Model market growth during the forecast period. The rise of personalized medicine is driving a significant force within the mice model market. The increased need for tailored preclinical testing. Traditionally, drug development relied on a "one-size-fits-all approach, leading to treatments that weren't always effective for everyone. However, personalized medicine focuses on individual patient needs, requiring therapies targeted to specific genetic variations. This shift necessitates a more nuanced approach to preclinical testing. Here's where the mice model market comes in. Mice with precise genetic modifications, mirroring specific patient mutations, is used to evaluate the efficacy and safety of personalized treatments. This allows researchers to test how a drug work for a particular patient population before moving to human trials. The ability to create these highly customized models with CRISPR and other gene editing advancements is a boon for the mice model market. It fosters a more efficient drug development pipeline, with therapies demonstrably effective for specific patient groups reaching human trials faster. This not only benefits pharmaceutical companies but also accelerates the delivery of life-saving treatments to patients in need. As personalized medicine takes centre stage, the ability to create highly specific mice models remain a crucial tool in developing effective therapies for a wider range of patients. Growing pipeline of pharmaceutical and biopharmaceutical companies. The pharmaceutical and biopharmaceutical landscape is experiencing a surge in new drug discovery and development activity, with a continuously growing pipeline of potential treatments. This trend has a significant positive impact on the mice model market. These companies rely heavily on preclinical testing to evaluate the safety and efficacy of potential drugs before human trials commence. As their pipelines increase, the demand for robust and reliable preclinical testing solutions within the mice model market grows in tandem. The mice model market offers a powerful tool for pharmaceutical companies the ability to create disease models in mice that closely mimic human conditions. This allows researchers to assess the potential effectiveness and potential side effects of new drugs in a controlled environment. With a growing number of drug candidates, the need for these in-vivo models within the mice model market becomes ever more crucial. Furthermore, the increasing focus on novel therapies, particularly those targeting specific diseases or patient populations, necessitates even more specialized testing models. The mice model market cater to this demand by providing mice with specific genetic modifications or disease states that mirror the target population. This tailored testing approach allows for a more accurate prediction of a drug's efficacy in humans, ultimately leading to a higher success rate in clinical trials. The increasing pipeline of pharmaceutical and biopharmaceutical companies directly translates to a thriving mice model industry. As the need for preclinical testing solutions grows alongside the development of new drugs, the demand for sophisticated and specialized mice models within the mice model market continue to be a major driver of industry growth.
Global Mice Model Market Segment Analysis
The mice model market is segmented by oncology (cancer), neurology (brain and nervous system), metabolic diseases (like diabetes), immunology (immune system), cardiovascular diseases (heart and blood vessels), and other diseases. In 2024, the oncology segment holds the biggest share of the market. This dominance is driven by the significant increase in research funding dedicated to developing personalized cancer treatments. A prime example is the National Cancer Institute (NCI), which has allocated a substantial portion of its research budget, around USD xx billion, towards various cancer research areas, including brain and central nervous system cancers. This funding directly translates to a higher demand for specialized mice models specifically designed for cancer research. Globally, breast and lung cancers were the most frequently diagnosed in 2020, accounting for 12.5% and 12.2% of all new cancer cases respectively. Colorectal cancer ranked third, with an estimated 1.9 million new cases diagnosed that year, representing 10.7% of global cases.The increasing number of cancer patients creates a ripple effect. It highlights the need for effective treatments, which in turn fuels research using mice models. This drives demand for various types of mice models, ultimately leading to market growth.
Rank Cancer New cases in 2020 1 Breast 2,261,419 2 Lung 2,206,771 3 Colorectal 1,931,590 4 Prostate 1,414,259 5 Stomach 1,089,103 6 Liver 905,677 7 Cervix uteri 604,127 8 Oesophagus 604,100 9 Thyroid 586,202 10 Bladder 573,278 11 Non-Hodgkin lymphoma 544,352 12 Pancreas 495,773 13 Leukaemia 474,519 14 Kidney 431,288 15 Corpus uteri 417,367 16 Lip, oral cavity 377,713 17 Melanoma of skin 324,635 18 Ovary 313,959 19 Brain, central nervous system 308,102 20 Larynx 184,615 Mice Model Market Segment Analysis:-
Based on model types mice model market is segmented into Inbred, Outbred, Hybrid, and genetically Engineered Mice. In 2024, inbred mice dominated the market. This dominance is due to their genetic uniformity. Because inbred mice are genetically identical, they offer consistent and reproducible results in research. This makes them ideal for studying complex traits and diseases, where researchers need to control for genetic variations. This advantage has significantly contributed to the growth of the inbred mice segment within the overall mice model market.
Global Mice Model Market Regional Analysis
North America is poised to be a leader in the mice model market during the forecast period. This growth is fuelled by a confluence of factors. Firstly, healthcare spending in the region is on the rise, which translates to more funding available for research and development. This increased investment directly translates to a greater demand for mice models to study various diseases and develop new treatments. The prevalence of both infectious and non-communicable diseases in North America is a growing concern. These diseases necessitate research using mice models to understand how they work and develop targeted therapies. In addition, the market itself is quite active, with companies collaborating and forming agreements to push the boundaries of research using mice models. This collaborative spirit fosters innovation and fuels market growth within North America.Mice Model Industry Ecosystem:-
Mice Model Market Scope: Inquire before buying
Global Mice Model Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 1.60 Bn. Forecast Period 2025 to 2032 CAGR: 6.8% Market Size in 2032: USD 2.71 Bn. Segments Covered: by Model Type Inbred Mice Genetically Engineered Mice Hybrid/Congenic Mice Outbred Mice by Technology CRISPR Microinjection Embryonic Stem Cell Injection Nuclear Transfer Other Technologies by Application Drug Discovery & Development Research Application by End-User Pharmaceutical & Biotechnology Companies Academic & Research Institutes CROs & CDMOs Mice Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Global Mice Model Market, Key Players:
Global Mice Model Providers in North America: 1. Laboratory Corporation of America Holdings (Burlington, North Carolina, USA) 2. Charles River Laboratories International, Inc. (Wilmington, Massachusetts, USA) 3. The Jackson Laboratory (Bar Harbor, Maine, USA) 4. Taconic Biosciences, Inc. (Germantown, New York, USA) 5. Crown Biosciences (San Diego, California, USA) 6. TransCure bioServices (Montreal, Quebec, Canada) 7. Cyagen Biosciences (Canton, Massachusetts, USA) 8. The Andersons, Inc. (Maumee, Ohio, USA) 9. Allentown, LLC (Allentown, New Jersey, USA)) Global Mice Model Providers in Europe: 10. Envigo (Huntingdon, Cambridgeshire, UK) [Previously known as Harlan Laboratories] 11. Janvier Labs (Yvonné, France) 12. Genoway (Lyon, France) 13. Ingenious Targeting Laboratory (Ghent, Belgium) Global Mice Model Providers in Asia-Pacific: 14. Trans Genic, Inc. (Fukuoka, Japan) 15. Harbour Antibodies Bv (Harbin, China) [Harbour Biomed subsidiary] 16. PolyGene (Beijing, China) 17. GVK BIO (Hyderabad, India) 18. Ozgene Pty Ltd. (Brisbane, Queensland, Australia) FAQs: 2. Which region has the largest share in Global Mice Model Market? Ans: North America region holds the highest share in 2024. 1. What was the Global Mice Model Market size in 2024? Ans: The Global Mice Model Market size was USD 1.60 Billion in 2024. 3. What segments are covered in Global Mice Model market? Ans: Global Mice Model Market is segmented into Model Types, Therapeutic Area, Application, and region. 4. Who are the key players in Global Mice Model market? Ans: The important key players in the Global Mice Model Market are – Laboratory Corporation of America Holdings (Burlington, North Carolina, USA), Charles River Laboratories International, Inc. (Wilmington, Massachusetts, USA), The Jackson Laboratory (Bar Harbor, Maine, USA), Taconic Biosciences, Inc. (Germantown, New York, USA), Crown Biosciences (San Diego, California, USA), TransCure bioServices (Montreal, Quebec, Canada), Cyagen Biosciences (Canton, Massachusetts, USA), The Andersons, Inc. (Maumee, Ohio, USA),Allentown, LLC (Allentown, New Jersey, USA)and Others. 5. What is the study period of this market? Ans: The Global Mice Model Market is studied from 2024 to 2032.
1. Mice Model Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Mice Model Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.4.1. Main suppliers and their market positioning 2.4.2. Key customers and adoption rates across different sectors 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Geographic distribution of major customers 2.6. Market Structure 2.6.1. Market Leaders 2.6.2. Market Followers 2.6.3. Emerging Players 2.7. Mergers and Acquisitions Details 3. Market Size Estimation Methodology 3.1.1. Bottom-Up Approach 3.1.2. Top-Down Approach 4. Market Dynamics 4.1. Mice Model Market Trends By Region 4.1.1. North America Mice Model Market Trends 4.1.2. Europe Mice Model Market Trends 4.1.3. Asia Pacific Mice Model Market Trends 4.1.4. South America Mice Model Market Trends 4.1.5. Middle East & Africa (MEA) Mice Model Market Trends 4.2. Mice Model Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. PORTER’s Five Forces Analysis 4.3.1. Threat of New Entrants 4.3.2. Threat of Substitutes 4.3.3. Bargaining Power of Suppliers 4.3.4. Bargaining Power of Buyers 4.3.5. Intensity of Competitive Rivalry 4.4. PESTLE Analysis 4.5. Regulatory Landscape By Region 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. South America 4.5.5. MEA 4.6. Analysis of Government Schemes and Initiatives For the Mice Model Industry 4.7. Value Chain Analysis 4.8. Supply Chain Analysis 4.9. Pricing Analysis 4.10. Mice Model Industry Ecosystem 4.10.1. Mice Model Vendors Role in Ecosystem 4.10.2. Mice Model Service Vendors Role in Ecosystem 4.10.3. Mice Model End Users Role in Ecosystem 4.11. Patent Analysis 4.11.1. Key Companies with the Highest number of Patents 4.11.2. Patent Registration Analysis 4.11.3. Number of Patents Granted Still 2024 4.12. Investment and Funding Scenario 4.12.1. Major Investment and Funding 5. Mice Model Market: Global Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 5.1. Mice Model Market Size and Forecast, By Model Type(2024-2032) 5.1.1. Inbred Mice 5.1.2. Genetically Engineered Mice 5.1.3. Hybrid/Congenic Mice 5.1.4. Outbred Mice 5.2. Mice Model Market Size and Forecast, By Technology(2024-2032) 5.2.1. CRISPR 5.2.2. Microinjection 5.2.3. Embryonic Stem Cell Injection 5.2.4. Nuclear Transfer 5.2.5. Other Technologies 5.3. Mice Model Market Size and Forecast, By Application(2024-2032) 5.3.1. Drug Discovery & Development 5.3.2. Research Application 5.4. Mice Model Market Size and Forecast, By End-Use(2024-2032) 5.4.1. Pharmaceutical & Biotechnology Companies 5.4.2. Academic & Research Institutes 5.4.3. CROs & CDMOs 5.5. Mice Model Market Size and Forecast, By Region (2024-2032) 5.5.1. North America 5.5.2. Europe 5.5.3. Asia Pacific 5.5.4. South America 5.5.5. MEA 6. North America Mice Model Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 6.1. North America Mice Model Market Size and Forecast, By Model Type(2024-2032) 6.1.1. Inbred Mice 6.1.2. Genetically Engineered Mice 6.1.3. Hybrid/Congenic Mice 6.1.4. Outbred Mice 6.2. North America Mice Model Market Size and Forecast, By Technology(2024-2032) 6.2.1. CRISPR 6.2.2. Microinjection 6.2.3. Embryonic Stem Cell Injection 6.2.4. Nuclear Transfer 6.2.5. Other Technologies 6.3. North America Mice Model Market Size and Forecast, By Application(2024-2032) 6.3.1. Drug Discovery & Development 6.3.2. Research Application 6.4. North America Mice Model Market Size and Forecast, By End-Use (2024-2032) 6.4.1. Pharmaceutical & Biotechnology Companies 6.4.2. Academic & Research Institutes 6.4.3. CROs & CDMOs 6.5. North America Mice Model Market Size and Forecast, By Country (2024-2032) 6.5.1. United States 6.5.1.1. United States Mice Model Market Size and Forecast, By Model Type(2024-2032) 6.5.1.1.1. Inbred Mice 6.5.1.1.2. Genetically Engineered Mice 6.5.1.1.3. Hybrid/Congenic Mice 6.5.1.1.4. Outbred Mice 6.5.1.2. United States Mice Model Market Size and Forecast, By Technology(2024-2032) 6.5.1.2.1. CRISPR 6.5.1.2.2. Microinjection 6.5.1.2.3. Embryonic Stem Cell Injection 6.5.1.2.4. Nuclear Transfer 6.5.1.2.5. Other Technologies 6.5.1.3. United States Mice Model Market Size and Forecast, By Application(2024-2032) 6.5.1.3.1. Drug Discovery & Development 6.5.1.3.2. Research Application 6.5.1.4. United States Mice Model Market Size and Forecast By End-Use (2024-2032) 6.5.1.4.1. Pharmaceutical & Biotechnology Companies 6.5.1.4.2. Academic & Research Institutes 6.5.1.4.3. CROs & CDMOs 6.5.2. Canada 6.5.2.1. Canada Mice Model Market Size and Forecast, By Model Type(2024-2032) 6.5.2.1.1. Inbred Mice 6.5.2.1.2. Genetically Engineered Mice 6.5.2.1.3. Hybrid/Congenic Mice 6.5.2.1.4. Outbred Mice 6.5.2.2. Canada Mice Model Market Size and Forecast, By Technology(2024-2032) 6.5.2.2.1. CRISPR 6.5.2.2.2. Microinjection 6.5.2.2.3. Embryonic Stem Cell Injection 6.5.2.2.4. Nuclear Transfer 6.5.2.2.5. Other Technologies 6.5.2.3. Canada Mice Model Market Size and Forecast, By Application(2024-2032) 6.5.2.3.1. Drug Discovery & Development 6.5.2.3.2. Research Application 6.5.2.4. Canada Mice Model Market Size and Forecast, By End-Use (2024-2032) 6.5.2.4.1. Pharmaceutical & Biotechnology Companies 6.5.2.4.2. Academic & Research Institutes 6.5.2.4.3. CROs & CDMOs 6.5.3. Mexico 6.5.3.1. Mexico Mice Model Market Size and Forecast, By Model Type(2024-2032) 6.5.3.1.1. Inbred Mice 6.5.3.1.2. Genetically Engineered Mice 6.5.3.1.3. Hybrid/Congenic Mice 6.5.3.1.4. Outbred Mice 6.5.3.2. Mexico Mice Model Market Size and Forecast, By Technology(2024-2032) 6.5.3.2.1. CRISPR 6.5.3.2.2. Microinjection 6.5.3.2.3. Embryonic Stem Cell Injection 6.5.3.2.4. Nuclear Transfer 6.5.3.2.5. Other Technologies 6.5.3.3. Mexico Mice Model Market Size and Forecast, By Application(2024-2032) 6.5.3.3.1. Drug Discovery & Development 6.5.3.3.2. Research Application 6.5.3.4. Mexico Mice Model Market Size and Forecast, By End-Use (2024-2032) 6.5.3.4.1. Pharmaceutical & Biotechnology Companies 6.5.3.4.2. Academic & Research Institutes 6.5.3.4.3. CROs & CDMOs 7. Europe Mice Model Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 7.1. Europe Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.2. Europe Mice Model Market Size and Forecast, By Technology(2024-2032) 7.3. Europe Mice Model Market Size and Forecast, By Application(2024-2032) 7.4. Europe Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5. Europe Mice Model Market Size and Forecast, By Country (2024-2032) 7.5.1. United Kingdom 7.5.1.1. United Kingdom Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.1.2. United Kingdom Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.1.3. United Kingdom Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.1.4. United Kingdom Mice Model Market Size and Forecast By End-Use (2024-2032) 7.5.2. France 7.5.2.1. France Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.2.2. France Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.2.3. France Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.2.4. France Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.3. Germany 7.5.3.1. Germany Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.3.2. Germany Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.3.3. Germany Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.3.4. Germany Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.4. Italy 7.5.4.1. Italy Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.4.2. Italy Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.4.3. Italy Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.4.4. Italy Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.5. Spain 7.5.5.1. Spain Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.5.2. Spain Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.5.3. Spain Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.5.4. Spain Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.6. Sweden 7.5.6.1. Sweden Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.6.2. Sweden Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.6.3. Sweden Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.6.4. Sweden Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.7. Austria 7.5.7.1. Austria Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.7.2. Austria Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.7.3. Austria Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.7.4. Austria Mice Model Market Size and Forecast, By End-Use (2024-2032) 7.5.8. Rest of Europe 7.5.8.1. Rest of Europe Mice Model Market Size and Forecast, By Model Type(2024-2032) 7.5.8.2. Rest of Europe Mice Model Market Size and Forecast, By Technology(2024-2032) 7.5.8.3. Rest of Europe Mice Model Market Size and Forecast, By Application(2024-2032) 7.5.8.4. Rest of Europe Mice Model Market Size and Forecast, By End-Use (2024-2032) 8. Asia Pacific Mice Model Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 8.1. Asia Pacific Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.2. Asia Pacific Mice Model Market Size and Forecast, By Technology(2024-2032) 8.3. Asia Pacific Mice Model Market Size and Forecast, By Application(2024-2032) 8.4. Asia Pacific Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5. Asia Pacific Mice Model Market Size and Forecast, By Country (2024-2032) 8.5.1. China 8.5.1.1. China Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.1.2. China Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.1.3. China Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.1.4. China Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.2. S Korea 8.5.2.1. S Korea Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.2.2. S Korea Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.2.3. S Korea Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.2.4. S Korea Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.3. Japan 8.5.3.1. Japan Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.3.2. Japan Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.3.3. Japan Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.3.4. Japan Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.4. India 8.5.4.1. India Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.4.2. India Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.4.3. India Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.4.4. India Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.5. Australia 8.5.5.1. Australia Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.5.2. Australia Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.5.3. Australia Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.5.4. Australia Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.6. ASEAN 8.5.6.1. ASEAN Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.6.2. ASEAN Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.6.3. ASEAN Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.6.4. ASEAN Mice Model Market Size and Forecast, By End-Use (2024-2032) 8.5.7. Rest of Asia Pacific 8.5.7.1. Rest of Asia Pacific Mice Model Market Size and Forecast, By Model Type(2024-2032) 8.5.7.2. Rest of Asia Pacific Mice Model Market Size and Forecast, By Technology(2024-2032) 8.5.7.3. Rest of Asia Pacific Mice Model Market Size and Forecast, By Application(2024-2032) 8.5.7.4. Rest of Asia Pacific Mice Model Market Size and Forecast, By End-Use (2024-2032) 9. South America Mice Model Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 9.1. South America Mice Model Market Size and Forecast, By Model Type(2024-2032) 9.2. South America Mice Model Market Size and Forecast, By Technology(2024-2032) 9.3. South America Mice Model Market Size and Forecast, By Application(2024-2032) 9.4. South America Mice Model Market Size and Forecast, By End-Use (2024-2032) 9.5. South America Mice Model Market Size and Forecast, By Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Mice Model Market Size and Forecast, By Model Type(2024-2032) 9.5.1.2. Brazil Mice Model Market Size and Forecast, By Technology(2024-2032) 9.5.1.3. Brazil Mice Model Market Size and Forecast, By Application(2024-2032) 9.5.1.4. Brazil Mice Model Market Size and Forecast, By End-Use (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Mice Model Market Size and Forecast, By Model Type(2024-2032) 9.5.2.2. Argentina Mice Model Market Size and Forecast, By Technology(2024-2032) 9.5.2.3. Argentina Mice Model Market Size and Forecast, By Application(2024-2032) 9.5.2.4. Argentina Mice Model Market Size and Forecast, By End-Use (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Mice Model Market Size and Forecast, By Model Type(2024-2032) 9.5.3.2. Rest Of South America Mice Model Market Size and Forecast, By Technology(2024-2032) 9.5.3.3. Rest Of South America Mice Model Market Size and Forecast, By Application(2024-2032) 9.5.3.4. Rest Of South America Mice Model Market Size and Forecast, By End-Use (2024-2032) 10. Middle East and Africa Mice Model Market Size and Forecast By Segmentation (By Value USD Bn) (2024-2032) 10.1. Middle East and Africa Mice Model Market Size and Forecast, By Model Type(2024-2032) 10.2. Middle East and Africa Mice Model Market Size and Forecast, By Technology(2024-2032) 10.3. Middle East and Africa Mice Model Market Size and Forecast, By Application(2024-2032) 10.4. Middle East and Africa Mice Model Market Size and Forecast, By End-Use (2024-2032) 10.5. Middle East and Africa Mice Model Market Size and Forecast, By Country (2024-2032) 10.5.1. South Africa 10.5.1.1. South Africa Mice Model Market Size and Forecast, By Model Type(2024-2032) 10.5.1.2. South Africa Mice Model Market Size and Forecast, By Technology(2024-2032) 10.5.1.3. South Africa Mice Model Market Size and Forecast, By Application(2024-2032) 10.5.1.4. South Africa Mice Model Market Size and Forecast, By End-Use (2024-2032) 10.5.2. GCC 10.5.2.1. GCC Mice Model Market Size and Forecast, By Model Type(2024-2032) 10.5.2.2. GCC Mice Model Market Size and Forecast, By Technology(2024-2032) 10.5.2.3. GCC Mice Model Market Size and Forecast, By Application(2024-2032) 10.5.2.4. GCC Mice Model Market Size and Forecast, By End-Use (2024-2032) 10.5.3. Rest Of MEA 10.5.3.1. Rest Of MEA Mice Model Market Size and Forecast, By Model Type(2024-2032) 10.5.3.2. Rest Of MEA Mice Model Market Size and Forecast, By Technology(2024-2032) 10.5.3.3. Rest Of MEA Mice Model Market Size and Forecast, By Application(2024-2032) 10.5.3.4. Rest Of MEA Mice Model Market Size and Forecast, By End-Use (2024-2032) 11. Company Profile: Key Players 11.1. The Jackson Laboratory 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis (Technological strengths and weaknesses) 11.1.5. Strategic Analysis (Recent strategic moves) 11.1.6. Recent Developments 11.2. Laboratory Corporation of America Holdings 11.3. Charles River Laboratories International, Inc. 11.4. Taconic Biosciences, Inc. 11.5. Crown Biosciences 11.6. TransCure bioServices 11.7. Cyagen Biosciences 11.8. The Andersons, Inc. 11.9. Allentown, LLC 11.10. Envigo 11.11. Janvier Labs 11.12. Genoway 11.13. Ingenious Targeting Laboratory 11.14. Trans Genic, Inc. 11.15. Harbour Antibodies Bv 11.16. PolyGene 11.17. GVK BIO 11.18. Ozgene Pty Ltd. 12. Key Findings 13. Analyst Recommendations 13.1. Attractive Opportunities for Players in the Mice Model Market 13.2. Future Outlooks 14. Mice Model Market: Research Methodology
